The Moving Average Convergence Divergence (MACD) for MED turned positive on October 14, 2026. Looking at past instances where MED's MACD turned positive, the stock continued to rise in 37 of 58 cases over the following month. The odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on MED as a result. In 58 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
MED moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MED crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where MED advanced for three days, in 150 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
MED broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MED entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.689) is normal, around the industry mean (7.621). MED has a moderately low P/E Ratio (-5.193) as compared to the industry average of (10.681). Projected Growth (PEG Ratio) (0.230) is also within normal values, averaging (4.440). MED's Dividend Yield (0.545) is considerably higher than the industry average of (0.080). P/S Ratio (0.416) is also within normal values, averaging (1.645).
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. MED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for TNL turned positive on September 24, 2026. Looking at past instances where TNL's MACD turned positive, the stock continued to rise in 42 of 51 cases over the following month. The odds of a continued upward trend are 82%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TNL's RSI Indicator exited the oversold zone, 18 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on TNL as a result. In 68 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
TNL moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where TNL advanced for three days, in 203 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
TNL broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TNL entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.040) is normal, around the industry mean (0.391). P/E Ratio (17.679) is within average values for comparable stocks, (25.274). Projected Growth (PEG Ratio) (0.050) is also within normal values, averaging (1.617). Dividend Yield (0.036) settles around the average of (0.185) among similar stocks. P/S Ratio (1.027) is also within normal values, averaging (2.686).
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. TNL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
MED | TNL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 36 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 48 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 51 | |
SMR RATING 1..100 | 94 | 3 | |
PRICE GROWTH RATING 1..100 | 44 | 48 | |
P/E GROWTH RATING 1..100 | 97 | 7 | |
SEASONALITY SCORE 1..100 | 39 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MED's Valuation (3) in the Specialty Stores industry is somewhat better than the same rating for TNL (48) in the Hotels Or Resorts Or Cruiselines industry. This means that MED’s stock grew somewhat faster than TNL’s over the last 12 months.
TNL's Profit vs Risk Rating (51) in the Hotels Or Resorts Or Cruiselines industry is somewhat better than the same rating for MED (100) in the Specialty Stores industry. This means that TNL’s stock grew somewhat faster than MED’s over the last 12 months.
TNL's SMR Rating (3) in the Hotels Or Resorts Or Cruiselines industry is significantly better than the same rating for MED (94) in the Specialty Stores industry. This means that TNL’s stock grew significantly faster than MED’s over the last 12 months.
MED's Price Growth Rating (44) in the Specialty Stores industry is in the same range as TNL (48) in the Hotels Or Resorts Or Cruiselines industry. This means that MED’s stock grew similarly to TNL’s over the last 12 months.
TNL's P/E Growth Rating (7) in the Hotels Or Resorts Or Cruiselines industry is significantly better than the same rating for MED (97) in the Specialty Stores industry. This means that TNL’s stock grew significantly faster than MED’s over the last 12 months.
| MED | TNL | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 68% |
| Momentum ODDS (%) | 1 day ago 61% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 66% | 1 day ago 67% |
| Advances ODDS (%) | 1 day ago 62% | 1 day ago 68% |
| Declines ODDS (%) | 15 days ago 83% | 18 days ago 61% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 57% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 57% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MED’s FA Score shows that 1 FA rating(s) are green while TNL’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MED’s TA Score shows that 4 TA indicator(s) are bullish while TNL’s TA Score has 5 bullish TA indicator(s).
MED (@Personnel Services) experienced а +2.11% price change this week, while TNL (@Consumer Sundries) price change was +7.26% for the same time period.
The average weekly price growth across all stocks in the @Personnel Services industry was +2.92%. For the same industry, the average monthly price growth was +2.23%, and the average quarterly price growth was -7.09%.
The average weekly price growth across all stocks in the @Consumer Sundries industry was -1.05%. For the same industry, the average monthly price growth was +3.73%, and the average quarterly price growth was +6.26%.
MED is expected to report earnings on Oct 26, 2026.
TNL is expected to report earnings on Oct 27, 2026.
Personnel Services comprise companies that provide staffing and human resources management solutions for businesses. Each company might be involved in one or more types of recruitment or employee solutions such as permanent or temporary staffing, career consulting, outsourcing, administrative services and many more. Some personnel services companies cater to large businesses, while some specialize in providing services to small/medium-sized organizations. These specialized services potentially expedite the process of getting the ‘right’ candidates and/or training them to meet the requirements of a business process. Some of the companies also cover other critical areas like internal auditing for a company. Robert Half International Inc., ManpowerGroup Inc. and Insperity, Inc. are examples of companies in the personnel services industry.
@Consumer Sundries (-1.05% weekly)Consumer sundries companies make products that usually do not have another classification, such as lawn and garden products, pest-control products, pet food and pet products like leashes, collars, and harnesses. Central Garden & Pet Company and Dogness (International) Corporation are examples of companies operating in this industry.
A.I.dvisor indicates that over the last year, TNL has been loosely correlated with SABR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TNL jumps, then SABR could also see price increases.
| Ticker / NAME | Correlation To TNL | 1D Price Change % | ||
|---|---|---|---|---|
| TNL | 100% | +0.21% | ||
| SABR - TNL | 52% Loosely correlated | +1.32% | ||
| CCL - TNL | 51% Loosely correlated | -0.81% | ||
| NCLH - TNL | 51% Loosely correlated | -0.32% | ||
| RCL - TNL | 46% Loosely correlated | -0.80% | ||
| EXPE - TNL | 45% Loosely correlated | +4.50% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBGK | 22.09 | 0.39 | +1.78% |
| iShares iBonds Dec 2054 Term Treasury ETF (IBGK) | |||
| IGLB | 47.14 | 0.66 | +1.42% |
| iShares 10+ Year Investment Grade Corporate Bond ETF (IGLB) | |||
| BKMS | 25.27 | 0.09 | +0.36% |
| BNY Mellon Municipal Short Duration ETF (BKMS) | |||
| EFFE | 25.88 | N/A | N/A |
| Harbor Osmosis Emerging Markets Resource Efficient ETF | |||
| PBDE | 31.83 | -0.13 | -0.41% |
| PGIM S&P 500 Buffer 20 ETF - December (PBDE) | |||